More on RYTM

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-8.0% Growth)
- Ratings (9.4 Score)
- Holders
- FDA

Upcoming Events

- Earnings (8/4/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Rhythm Pharmaceuticals (NQ:RYTM)
Delayed: 106.60 +0.51 (0.48%)
Prev. Close $106.09  
Open$104.92 
52 Wk High$ 
52 Wk Low$ 
Day High$108.40 
Day Low$104.20 
P/E N/A  
EPS$ 
Volume773,302 

Friends, Peers and Foes (?): CHKP, COF, CPRI, DLTR, KKR (more...)

Jul 14, 2026 04:13 AM Rhythm Pharmaceuticals (RYTM) Reiterated at Market Outperform by Citizens
Jul 8, 2026 05:07 PM Rhythm Pharmaceuticals TRANSCEND trial results published in NEJM
Jul 8, 2026 05:07 PM Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEND Trial Results in Acquired Hypothalamic Obesity
Jul 7, 2026 08:00 AM Rhythm Pharmaceuticals (RYTM) PT Raised to $141 at RBC Capital
Jul 2, 2026 04:53 PM Form 4 RHYTHM PHARMACEUTICALS, For: Jul 01 Filed by: Garfield Alastair
Jul 1, 2026 12:00 PM This biotech stock is on TD Cowen's best smidcap ideas list
Jun 25, 2026 06:10 PM Form 4 RHYTHM PHARMACEUTICALS, For: Jun 23 Filed by: JEAN CHRISTOPHE
Jun 25, 2026 06:08 PM Form 4 RHYTHM PHARMACEUTICALS, For: Jun 23 Filed by: MCGIRR DAVID W J
Jun 25, 2026 06:07 PM Form 4 RHYTHM PHARMACEUTICALS, For: Jun 23 Filed by: TETRAULT LYNN A.
Jun 25, 2026 06:03 PM Form 4 RHYTHM PHARMACEUTICALS, For: Jun 23 Filed by: Arbuckle Stuart A
View All Articles

Entities mentioned with RYTM

View All Entities